CN1030641C - Preparation for medicine eliminating stone from human body - Google Patents
Preparation for medicine eliminating stone from human body Download PDFInfo
- Publication number
- CN1030641C CN1030641C CN90106071A CN90106071A CN1030641C CN 1030641 C CN1030641 C CN 1030641C CN 90106071 A CN90106071 A CN 90106071A CN 90106071 A CN90106071 A CN 90106071A CN 1030641 C CN1030641 C CN 1030641C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- rhizoma
- rhizome
- stir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a preparation method of a medicine for eliminating calculi in a human body. A medicine is prepared from the raw materials of the Chinese medicinal herbs of desmodium with large leaves, lygodium, virgate wormwood herb, costus root, fructus aurantii, green tangerine peel, white peony root from Hangzhou of China, curcuma aromatica, common prism rhizome, rhizome zedoariae, cowherb seed, stir-baked gardenia, mongolian snakegourd root, angelica, chicken's gizzard-membrane, parched hawthorn fruit, Chinese paris rhizome, sauted turtle shell, stiff silkworm, olibanum, myrrh and stir-baked rhizome corydalis with vinegar. The medicine prepared by the present invention can be used for treating gallstone with the recovery rate of 70%, and effective rate approaches to 90%.
Description
The invention belongs to manufacture method of medicine, relate to a kind of manufacture method of medicine of eliminating calculus in human body.
The treatment cholelithiasis mainly contains three kinds of methods both at home and abroad at present, and promptly surgical resection method, lithotrite rubble therapy, the combination of Chinese and Western medicine are based on tcm therapy.Surgical operation can excise calculus, but still can not change the factor that produces calculus, therefore still exists the recurrence problem, as retained calculus, calculus regeneration etc.The common clinically calculus of herein taking out, the other side are given birth to the phenomenon of calculus again.And can cause damage, adhesion, narrow problem to tissue through operative treatment.The rubble therapy is in the exploratory stage at present.Only be applicable to that in general gallbladder function is good, single-shot calculus patient.Is main at China's mixed calculus for many, bile pigment calculus, multiple often.Condition cholelithiasis patient course of disease length, thickening of capsule wall of gallbladder, gallbladder function are poor.Though pulverized big calculus, number increases, the gallbladder mouth is again little, still has the problem of a discharge, emptying.Shock wave can produce certain damage to tissue, it should be noted that remote effect especially, also awaits further observational study.Therapy of combining Chinese and Western medicine, mainly treat cholesterol calculus based on present used chenodeoxycholic acid of the method for the traditional Chinese medical science and male deoxycholic acid.This class calculus is in the majority in west American-European countries, needs to obey 2 years half a year to one; Medicines such as uralyt and cholelithiasis are logical still need further research by clinical observation.This class medicine is domestic to also have " gallbladder benefiting and lithagogue infusion ", and according to 199 routine cholelithiasis patients are observed, lithagogue rate 62 examples account for 52.1%, discharge calculus greater than one centimetre less than two centimetres.(" Liaoning Journal of Traditional Chinese Medicine " 1986.No12)
Purpose of the present invention provides a kind of manufacture method of medicine of eliminating calculus in human body, can dissolve calculus in human body effectively with the medicine of manufacturing of the present invention, improves lithagogue rate and human body is not had any infringement.
The present invention is achieved through the following technical solutions: a kind of manufacture method of medicine of eliminating calculus in human body, form by the Chinese herbal medicine process of preparing Chinese medicine, raw material is selected Herba Lysimachiae 10~120g for use, Spora Lygodii 10~60g, Herba Artemisiae Scopariae 10~60g, Radix Aucklandiae (Radix Vladimiriae) 3~20g, Fructus Aurantii 5~30g, each 3~20g of green Pericarpium Citri Reticulatae, Radix Paeoniae Alba 6~60g, Radix Curcumae 6~30g, rhizoma sparganic 6~30g, Rhizoma Curcumae 5~30g, Semen Vaccariae 5~60g, Fructus Gardeniae Preparatus 3~20g, Radix Trichosanthis 6~60g, Radix Angelicae Sinensis 5~30g, Endothelium Corneum Gigeriae Galli 3~60g, Fructus Crataegi (parched to brown) 6~60g, Rhizoma Paridis 3~15g, Carapax Trionycis (processed) 6~60g, Bombyx Batryticatus 3~30g, each 3~15g of Olibanum Myrrha, stir-baked RHIZOMA CORYDALIS with vinegar 3~30g, process other first and go into earlier, add clout after 10~20 minutes with decocting.
The invention will be further described below in conjunction with most preferred embodiment of the present invention.
Press the prescription of Herba Lysimachiae 10g, Spora Lygodii 10g, Herba Artemisiae Scopariae 10g, Radix Aucklandiae (Radix Vladimiriae) 3g, Fructus Aurantii 5g, each 3g of green Pericarpium Citri Reticulatae, Radix Paeoniae Alba 6g, Radix Curcumae 6g, rhizoma sparganic 6g, Rhizoma Curcumae 5g, Semen Vaccariae 5g, Fructus Gardeniae Preparatus 3g, Radix Trichosanthis 6g, Radix Angelicae Sinensis 5g, Endothelium Corneum Gigeriae Galli 3g, Fructus Crataegi (parched to brown) 6g, Rhizoma Paridis 3g, Carapax Trionycis (processed) 6g, Bombyx Batryticatus 3g, each 3g of Olibanum Myrrha, stir-baked RHIZOMA CORYDALIS with vinegar 3g and press the process of preparing Chinese medicine of decocting Chinese medicine method.
The medicine of the elimination calculus in human body made from the present invention since in 1972 in clinical use.According to 480 routine cholelithiasis patient statistics, wherein male's 183 examples account for 38%, women's 297 examples account for 62%, 30~50 years old person's 384 example and account for 80%, and senior people is 80 years old, and the youngest person is 8 years old.The big person of calculus is long 4.1 centimetres, wide 3.3 centimetres, high 2.3 centimetres before the medication, and the many persons of number are hundreds of routine microliths, and medical history is the longest to be 23 years.Medication one month is transference cure, emptying calculus person 336 examples to the half a year, account for 70%; Condition of illness alleviates or disappears, and discharges calculus person's 84 examples, accounts for 17.5%; Condition of illness alleviates, calculus no change person 60 examples, accounts for 12.5%.The litholysis situation: former 4.1 centimetres of persons contract to 3.1 centimetres, and 1.9 centimetres are contracted to 0.9 centimetre, and 1.4 centimetres are contracted to 0.7 centimetre, contract to 0.5 centimetre greater than 1 centimetre of person.All kinds of patient's curative effect statistical conditions are seen attached list.
Cholelithiasis is a kind of chronic refractory disease, and its formation is a very long process, and " pathologic bile " is lithogenous internal environment with " pathologic biliary tract ".According to theory of Chinese medical science, " damp and hot " is the weight factor that forms calculus, the greasy or pungent stimulation food of surfeit, overworked, feelings will is not relaxed or depression, anger, cold stimulation etc. are then brought out primary disease easily.The medicine of producing with the present invention promptly is intended to fundamentally eliminate the focus in the human body, has administered the pathologic biliary tract, has changed pathologic bile, dissolving calculus in vivo, so cure rate reaches 70%, effective percentage is near 90%.
Subordinate list: 480 routine cholelithiasis patient curative effect statistics
Stone location | The example number | Therapeutic effect | ||
Calculus | Effectively | Invalid | ||
Gallbladder | 57 | 22 | 18 | 17 |
Gallbladder and bile duct | 73 | 57 | 12 | 4 |
Common bile duct | 190 | 152 | 20 | 18 |
Hepatic duct | 160 | 105 | 34 | 21 |
Amount to | 480 | 336 | 84 | 60 |
Percentage ratio | 100% | 70% | 17.5% | 12.5% |
Claims (2)
1, a kind of manufacture method of medicine of eliminating calculus in human body, it is characterized in that raw material selects Herba Lysimachiae 10~120g for use, Spora Lygodii 10~60g, Herba Artemisiae Scopariae 10~60g, Radix Aucklandiae (Radix Vladimiriae) 3~20g, Fructus Aurantii 5~30g, each 3~20g of green Pericarpium Citri Reticulatae, Radix Paeoniae Alba 6~60g, Radix Curcumae 6~30g, rhizoma sparganic 6~30g, Rhizoma Curcumae 5~30g, Semen Vaccariae 5~60g, Fructus Gardeniae Preparatus 3~20g, Radix Trichosanthis 6~60g, Radix Angelicae Sinensis 5~30g, Endothelium Corneum Gigeriae Galli 3~60g, Fructus Crataegi (parched to brown) 6~60g, Rhizoma Paridis 3~15g, Carapax Trionycis (processed) 6~60g, Bombyx Batryticatus 3~30g, each 3~15g of Olibanum Myrrha, stir-baked RHIZOMA CORYDALIS with vinegar 3~30g, preparation technology is that Carapax Trionycis (processed) is gone into earlier, add other raw material after 10~20 minutes with decocting, decoct promptly.
2, according to the method for claim 1, the prescription that it is characterized in that raw material is Herba Lysimachiae 10g, Spora Lygodii 10g, Herba Artemisiae Scopariae 10g, Radix Aucklandiae (Radix Vladimiriae) 3g, Fructus Aurantii 5g, each 3g of green Pericarpium Citri Reticulatae, Radix Paeoniae Alba 6g, Radix Curcumae 6g, rhizoma sparganic 6g, Rhizoma Curcumae 5g, Semen Vaccariae 5g, Fructus Gardeniae Preparatus 3g, Radix Trichosanthis 6g, Radix Angelicae Sinensis 5g, Endothelium Corneum Gigeriae Galli 3g, Fructus Crataegi (parched to brown) 6g, Rhizoma Paridis 3g, Carapax Trionycis (processed) 6g, Bombyx Batryticatus 3g, each 3g of Olibanum Myrrha, stir-baked RHIZOMA CORYDALIS with vinegar 3g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN90106071A CN1030641C (en) | 1990-12-25 | 1990-12-25 | Preparation for medicine eliminating stone from human body |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN90106071A CN1030641C (en) | 1990-12-25 | 1990-12-25 | Preparation for medicine eliminating stone from human body |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1062840A CN1062840A (en) | 1992-07-22 |
CN1030641C true CN1030641C (en) | 1996-01-10 |
Family
ID=4879780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN90106071A Expired - Fee Related CN1030641C (en) | 1990-12-25 | 1990-12-25 | Preparation for medicine eliminating stone from human body |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1030641C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1055003C (en) * | 1996-11-28 | 2000-08-02 | 崔圣注 | Medicine for curing calculus in human body |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1061853C (en) * | 1993-07-07 | 2001-02-14 | 遵义地区彭显和外敷结石症研究所 | Traditional Chinese herbal medicine product for treating lithiasis diseases by external application |
CN1049832C (en) * | 1995-08-08 | 2000-03-01 | 张振礼 | Medicine for lithiasis and its preparing method |
CN1062462C (en) * | 1996-08-07 | 2001-02-28 | 吴殿臣 | Medicine for treatment of renal lithiasis, liver and gall lithiasis |
CN1065134C (en) * | 1998-07-13 | 2001-05-02 | 戴伸柱 | Quick-acting preparation for litholysis |
CN100339121C (en) * | 2005-11-22 | 2007-09-26 | 陈光友 | Chinese medicine for treating calculus |
CN102727831B (en) * | 2012-07-06 | 2013-08-28 | 许瑞琴 | Traditional Chinese medicine for treating cholelithiasis |
-
1990
- 1990-12-25 CN CN90106071A patent/CN1030641C/en not_active Expired - Fee Related
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1055003C (en) * | 1996-11-28 | 2000-08-02 | 崔圣注 | Medicine for curing calculus in human body |
Also Published As
Publication number | Publication date |
---|---|
CN1062840A (en) | 1992-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104984297A (en) | Application of pharmaceutical composition in preparation of drugs for treating amenorrhea | |
CN104922543A (en) | Medicine composite for treating amenorrhea and preparation method thereof | |
CN1321674C (en) | Medicine for treating woman sterility | |
CN105617151A (en) | Powder boiling type traditional Chinese medicine antibacterial and anti-inflammatory agent, preparation method and applications thereof | |
CN1030641C (en) | Preparation for medicine eliminating stone from human body | |
CN104258292A (en) | Drug for department of obstetrics and gynecology for treating pregnancy complication and manufacturing method thereof | |
CN101987138A (en) | Chinese medicinal preparation for treating impotence | |
CN101791385B (en) | Medicine for treating psoriasis | |
CN103989907A (en) | Traditional Chinese medicine composition for treating amyloidosis cutis | |
CN101332268B (en) | Medicine for treating rhinitis, sinusitis | |
CN1994403A (en) | Pharmaceutical composition for promoting blood circulation and preparation method thereof | |
CN1060368C (en) | Traditional Chinese medicine Jinjiangkebao for treating cough | |
CN101658636B (en) | Chinese medical composition for treating coronary heart disease | |
CN103536866B (en) | Traditional Chinese medicine composition for treating inflammatory intestinal obstruction after abdominal operation and application thereof | |
CN105288538A (en) | Application of medicine composition for preparing medicine for treating amenorrhea | |
CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
CN103585517A (en) | Drug composition for treating hepatitis and cholecystitis and preparation method thereof | |
CN103191345B (en) | Postoperative drug for chronic peptic ulcer and esophagitis syndrome | |
CN101766749A (en) | Chinese patent medicine for treating chronic rhinitis and nasosinusitis | |
CN105106783A (en) | Traditional Chinese medicine composition for treating chronic appendicitis and application thereof | |
CN105169111A (en) | Traditional Chinese medicine composition for treating chronic urticaria and application of traditional Chinese medicine composition | |
CN105343793A (en) | Traditional Chinese medicine composition for treating gallstones and preparation method thereof | |
CN105709193A (en) | Artemisia argyi Levl-containing traditional Chinese medicine preparation for treating chronic enteritis and preparation method thereof | |
CN105343688A (en) | Medicine composition for treating myocardial infarction and application thereof | |
CN105106692A (en) | Traditional Chinese medicinal composition for gallstone postoperative recovery and preparation method of traditional Chinese medicinal composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |